227 related articles for article (PubMed ID: 26097869)
1. Induction of functional Brm protein from Brm knockout mice.
Thompson KW; Marquez SB; Lu L; Reisman D
Oncoscience; 2015; 2(4):349-61. PubMed ID: 26097869
[TBL] [Abstract][Full Text] [Related]
2. SWI/SNF chromatin-remodeling enzymes Brahma-related gene 1 (BRG1) and Brahma (BRM) are dispensable in multiple models of postnatal angiogenesis but are required for vascular integrity in infant mice.
Wiley MM; Muthukumar V; Griffin TM; Griffin CT
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25904594
[TBL] [Abstract][Full Text] [Related]
3. SWI/SNF complexes containing Brahma or Brahma-related gene 1 play distinct roles in smooth muscle development.
Zhang M; Chen M; Kim JR; Zhou J; Jones RE; Tune JD; Kassab GS; Metzger D; Ahlfeld S; Conway SJ; Herring BP
Mol Cell Biol; 2011 Jul; 31(13):2618-31. PubMed ID: 21518954
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
[TBL] [Abstract][Full Text] [Related]
5. Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development.
Marquez-Vilendrer SB; Rai SK; Gramling SJ; Lu L; Reisman DN
Oncoscience; 2016; 3(11-12):322-336. PubMed ID: 28105457
[TBL] [Abstract][Full Text] [Related]
6. BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions
Marquez-Vilendrer SB; Rai SK; Gramling SJ; Lu L; Reisman DN
Oncoscience; 2016; 3(11-12):337-350. PubMed ID: 28105458
[TBL] [Abstract][Full Text] [Related]
7. BRM: the core ATPase subunit of SWI/SNF chromatin-remodelling complex-a tumour suppressor or tumour-promoting factor?
Jancewicz I; Siedlecki JA; Sarnowski TJ; Sarnowska E
Epigenetics Chromatin; 2019 Nov; 12(1):68. PubMed ID: 31722744
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers.
Papillon JPN; Nakajima K; Adair CD; Hempel J; Jouk AO; Karki RG; Mathieu S; Möbitz H; Ntaganda R; Smith T; Visser M; Hill SE; Hurtado FK; Chenail G; Bhang HC; Bric A; Xiang K; Bushold G; Gilbert T; Vattay A; Dooley J; Costa EA; Park I; Li A; Farley D; Lounkine E; Yue QK; Xie X; Zhu X; Kulathila R; King D; Hu T; Vulic K; Cantwell J; Luu C; Jagani Z
J Med Chem; 2018 Nov; 61(22):10155-10172. PubMed ID: 30339381
[TBL] [Abstract][Full Text] [Related]
9. Non-targeted metabolomics of
Banerjee R; Bultman SJ; Holley D; Hillhouse C; Bain JR; Newgard CB; Muehlbauer MJ; Willis MS
Metabolomics; 2015 Oct; 11(5):1287-1301. PubMed ID: 26392817
[TBL] [Abstract][Full Text] [Related]
10. Functional redundancy of SWI/SNF catalytic subunits in maintaining vascular endothelial cells in the adult heart.
Willis MS; Homeister JW; Rosson GB; Annayev Y; Holley D; Holly SP; Madden VJ; Godfrey V; Parise LV; Bultman SJ
Circ Res; 2012 Aug; 111(5):e111-22. PubMed ID: 22740088
[TBL] [Abstract][Full Text] [Related]
11. The SWI/SNF subunit BRG1 affects alternative splicing by changing RNA binding factor interactions with nascent RNA.
Gañez-Zapater A; Mackowiak SD; Guo Y; Tarbier M; Jordán-Pla A; Friedländer MR; Visa N; Östlund Farrants AK
Mol Genet Genomics; 2022 Mar; 297(2):463-484. PubMed ID: 35187582
[TBL] [Abstract][Full Text] [Related]
12. BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility.
Willis MS; Holley DW; Wang Z; Chen X; Quintana M; Jensen BC; Tannu M; Parker J; Jeyaraj D; Jain MK; Wolfram JA; Lee HG; Bultman SJ
J Mol Cell Cardiol; 2017 Apr; 105():99-109. PubMed ID: 28232072
[TBL] [Abstract][Full Text] [Related]
13. The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes.
Xu Y; Zhang J; Chen X
J Biol Chem; 2007 Dec; 282(52):37429-35. PubMed ID: 17938176
[TBL] [Abstract][Full Text] [Related]
14. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE
Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
[TBL] [Abstract][Full Text] [Related]
16. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.
Reisman DN; Sciarrotta J; Wang W; Funkhouser WK; Weissman BE
Cancer Res; 2003 Feb; 63(3):560-6. PubMed ID: 12566296
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of Drosophila Brahma on CDK-phosphorylation sites is important for cell cycle regulation and differentiation.
Roesley SNA; La Marca JE; Deans AJ; Mckenzie L; Suryadinata R; Burke P; Portela M; Wang H; Bernard O; Sarcevic B; Richardson HE
Cell Cycle; 2018; 17(13):1559-1578. PubMed ID: 29963966
[TBL] [Abstract][Full Text] [Related]
18. BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo.
Bultman SJ; Holley DW; G de Ridder G; Pizzo SV; Sidorova TN; Murray KT; Jensen BC; Wang Z; Bevilacqua A; Chen X; Quintana MT; Tannu M; Rosson GB; Pandya K; Willis MS
Cardiovasc Pathol; 2016; 25(3):258-269. PubMed ID: 27039070
[TBL] [Abstract][Full Text] [Related]
19. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.
Banine F; Bartlett C; Gunawardena R; Muchardt C; Yaniv M; Knudsen ES; Weissman BE; Sherman LS
Cancer Res; 2005 May; 65(9):3542-7. PubMed ID: 15867346
[TBL] [Abstract][Full Text] [Related]
20. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D
Oncogene; 2007 Oct; 26(49):7058-66. PubMed ID: 17546055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
